In February 2026, Bryan Johnson posted three words on X that summarized a $400 million philosophy: “Death is optional.” Below the post, he announced Immortals, a longevity program priced at $1 million per year with three spots. Applicants would receive his exact anti-aging protocol, a dedicated concierge team, round-the-clock AI guidance, and continuous biomarker tracking. The waitlist filled immediately. The Bryan Johnson longevity protocol had graduated from personal experiment to luxury product, and the man who sold Braintree to PayPal for $800 million was now selling the only thing more expensive than a payments company: time.

Johnson is 48 years old. He claims the heart of a 37-year-old, the skin of a 28-year-old, and the lung capacity of an 18-year-old. He swallows more than 100 pills every morning, sleeps in a precisely controlled environment, eats his last meal before noon, and submits to enough medical testing to fill a small hospital’s annual quota. His annual spend on staying alive (or, more precisely, on staying young) exceeds $2 million. Whether you find him inspiring or insufferable, he is the most visible figure in the longevity billionaire movement, and his protocol has reshaped how wealthy people think about aging.

From Provo to PayPal: The $800 Million Exit

Bryan Johnson was born on August 22, 1977, in Provo, Utah. His early career included selling cell phones to fund his education at Brigham Young University, where he earned a business degree. He later completed an MBA at the University of Chicago. His first ventures failed. Those failures taught him to iterate quickly and tolerate uncertainty, skills that would prove useful when he founded Braintree in 2007.

Braintree was a payment processing platform built for e-commerce businesses. Under Johnson’s leadership, the company grew fast enough to attract Venmo, a peer-to-peer payments app he acquired for $26.2 million in 2012. A year later, PayPal (then operating under eBay) acquired the combined Braintree-Venmo operation for $800 million in cash. Johnson’s personal take from the sale was reportedly between $300 million and $400 million before taxes.

After the exit, Johnson did not buy a yacht or retire to a beach. He launched OS Fund in 2014, a $100 million venture capital firm investing in frontier technology: genomics, synthetic biology, artificial intelligence. In 2016, he founded Kernel, a neurotechnology company building non-invasive brain imaging devices. Kernel raised over $110 million. Each move pushed Johnson further from fintech and closer to the question that would define his next decade: what can technology do to the human body?

Project Blueprint: What $2 Million a Year Actually Buys

Johnson launched Project Blueprint in 2021 with a straightforward thesis: aging is a measurable process, and measurable processes can be optimized. His protocol involves a team of more than 30 doctors and medical professionals who monitor the biological age of his organs, track hundreds of biomarkers, and adjust his regimen based on continuous data.

The daily routine is punishing by any standard. Johnson wakes at the same time every day and exercises within a strict window. He eats a calorie-controlled vegan diet with his final meal before noon. His sleep protocol involves no screens for an hour before bed and total darkness from a fixed bedtime. His personal expenses outside of Blueprint run approximately $15,000 per month, modest for someone worth hundreds of millions. Nearly everything else goes back into the protocol or his companies.

Johnson publishes his results openly. The Bryan Johnson longevity protocol is documented on his Blueprint website, where he shares his supplement stack, diet plan, exercise routine, and test results for anyone to follow. That transparency is both the brand and the business model. By giving away the protocol for free, he built an audience of millions. By proving (or at least claiming to prove) that the protocol works on his own body, he created a credibility moat that no competitor can easily cross.

The 100-Pill Morning: Inside the Supplement Stack

Johnson’s daily supplement regimen for 2026 includes more than 100 pills, powders, and oils targeting energy production, cellular repair, metabolism, and biological aging. The core compounds read like a graduate-level pharmacology syllabus. NMN (nicotinamide mononucleotide) or NR (nicotinamide riboside) to boost NAD+ levels, which decline with age and play a critical role in DNA repair. Calcium alpha-ketoglutarate, shown to extend lifespan and reduce chronic inflammation in animal studies. Spermidine, which supports autophagy (the body’s process of clearing damaged cellular components). Fisetin, a senolytic compound that targets aged “zombie” cells.

Resveratrol, found naturally in grapes and berries, may support mitochondrial function and partially mimic calorie restriction. NDGA, a plant-derived antioxidant shown to extend male mouse lifespan, is taken at 50 milligrams daily. CoQ10 supports cellular energy production. The list continues through dozens of additional compounds, each selected based on published research and adjusted according to Johnson’s own biomarker responses.

In 2026, Johnson made several alterations to his stack, updating dosages and adding new compounds based on fresh data. The Bryan Johnson longevity protocol is not static. It is a rolling experiment with a sample size of one. Critics note that most longevity supplements lack robust human clinical trial data. Johnson’s counter is that waiting for 20-year trials means dying before the results arrive. For a man who sold a company for $800 million on the thesis that speed beats caution, the logic is internally consistent even if scientifically contested.

Immortals: The $1 Million Program That Sold Out Instantly

On February 12, 2026, Johnson announced Immortals on X. Three spots. One million dollars per year. The pitch: receive the exact protocol Johnson has followed for five years, managed by a dedicated team with full concierge support. Applicants must pass an interview process and hire a dedicated assistant to execute the regimen. Continuous tracking, extensive testing, and millions of biological data points are included.

BryanAI, an artificial intelligence trained on Johnson’s personal health data, provides 24/7 guidance. The AI component is strategic. It signals Johnson’s bet that his protocol can be systematized, abstracted from his body, and delivered to others through software. If Immortals works, the pricing model scales downward over time. The $1 million version is the prototype. Cheaper tiers are coming.

For skeptics, the price tag is the punchline. For Johnson, it is the business model. Longevity is now a market segment, not a science experiment. The Bryan Johnson longevity protocol generates revenue through Immortals, through the Blueprint supplement line, through content and partnerships, and through the attention economy itself. Johnson’s social media posts routinely pull millions of impressions. His supplement recommendations move consumer markets. Whether or not the protocol extends life, it has already created a business.

Bryan Johnson Net Worth: $400 Million and a Very Specific Budget

Estimates of Bryan Johnson’s net worth in 2026 range from $400 million to $500 million. The core wealth came from the Braintree exit. Subsequent investments through OS Fund, his stake in Kernel, and Blueprint-related revenue contribute to the total. The number has likely decreased from the post-sale peak, which is by design. Johnson has committed significant capital to ventures that are long-term bets: Kernel is still privately held, OS Fund investments are illiquid, and Blueprint is a cost center that produces cultural capital more than cash flow.

His personal spending tells a specific story. Approximately $2 million per year goes to the longevity protocol. Monthly personal expenses sit around $15,000. He does not live lavishly by billionaire standards. There is no private island, no mega-yacht, no collection of rare cars. In Bourdieu’s framework, Johnson has converted economic capital into symbolic capital at an unusual exchange rate: he spends less on luxury goods than most people in his bracket, and more on being seen as the person who solved aging.

That positioning has commercial value. Blueprint products, speaking fees, documentary deals (the Netflix film “Don’t Die” drew global attention), and the Immortals program all monetize the symbolic capital Johnson has built. His net worth is not just a number. It is a reinvestment thesis: spend money becoming the most famous longevity advocate on earth, then earn it back by selling the protocols and products that fame enables.

The Controversy Column

Johnson’s public persona generates attention and criticism in roughly equal measure. He documented a series of plasma transfusions that included his teenage son as a donor and his elderly father as a recipient, a multi-generational blood exchange that earned widespread mockery and genuine ethical questions. He later discontinued the plasma component, saying the data did not support continuing.

His social media presence oscillates between rigorous health data and provocations designed to go viral. A 2026 post about having zero microplastics in his testes pulled 9.3 million impressions. A subsequent post about his intimate life with his wife drew similar numbers. Johnson appears to understand that outrage and curiosity are both forms of attention, and attention is the raw material of the longevity economy.

Scientists offer mixed reviews. Some praise his transparency and willingness to self-experiment. Others note that a sample size of one proves nothing, that most of his supplements lack rigorous human trial data, and that his claims about biological age reversal rely on epigenetic clocks whose accuracy is still debated. Johnson’s position is consistent: do what the best available science suggests while waiting for better science to arrive. For a man spending $2 million a year on the bet, the conviction is difficult to dismiss even when the evidence is incomplete.

What the East End Can Learn from Bryan Johnson

Johnson’s protocol costs $2 million because he employs 30 doctors and runs custom experiments. The same underlying treatments, NAD+ infusions, red light therapy, hyperbaric oxygen, peptide protocols, supplement stacking, and biomarker tracking, are available at a fraction of that cost along the East End longevity corridor. Hamptons BioMed at 223 Hampton Road in Southampton offers NAD+ drips, the East End’s first medical-grade hyperbaric chamber, red light therapy, exosomes, and epigenetic counseling. A client spending $5,000 to $20,000 over a summer season can access 80% of what Johnson’s protocol delivers.

The gap between the $2 million version and the $5,000 version is not the science. It is the monitoring infrastructure, the custom compounding, and the dedicated medical team. For the East End summer population, the monitoring gap is narrowing fast. Functional lab panels that cost $10,000 five years ago now cost $2,000. Wearable devices track sleep, heart rate variability, blood oxygen, and activity with clinical-grade accuracy. The Bryan Johnson longevity protocol was designed for one body. The principles behind it are designed for everyone.

For the Hamptons wellness clinics reading this, Johnson is not the competition. He is the marketing department. Every time he posts a supplement recommendation or a biological age result, he drives demand for the same treatments available at your clinic. The question is whether your brand is positioned to capture that demand when it arrives on the East End.

Where The Conversation Continues

Bryan Johnson’s protocol is one story in a much larger series. Social Life Magazine is building the most comprehensive editorial treatment of the longevity economy in the Hamptons. The series covers the billionaires funding the science, the clinics delivering the treatments, and the cultural shift reshaping how wealth intersects with wellness on the South Fork.

If you operate in the longevity, wellness, or biohacking space and want editorial visibility with a high-net-worth East End audience, reach out directly at cass.almendral@sociallifemagazine.com.

For brands seeking premium placement, explore our Paid Feature options. A feature in Social Life Magazine puts your name alongside the people and institutions shaping the longevity economy.

Stay current on longevity, luxury, and everything in between. Sign up at sociallifemagazine.com for weekly coverage you will not find elsewhere.

Polo Hamptons returns July 18 and 25, 2026, at 900 Lumber Lane, Bridgehampton. BMW is the title sponsor. For sponsorship inquiries, visit polohamptons.com.

Already a reader? Share this piece with someone building in the longevity space, or subscribe to Social Life Magazine for five summer issues and Fall/Winter editions delivered to your door.

If this journalism matters to you, support it directly via PayPal. Independent publishing on the East End runs on readers who believe the story is worth telling.

Frequently Asked Questions

How much does Bryan Johnson spend on his longevity protocol?

Bryan Johnson spends approximately $2 million per year on his longevity protocol, Project Blueprint. This covers a team of more than 30 medical professionals, over 100 daily supplements, extensive diagnostic testing, experimental treatments, and specialized nutrition. In February 2026, he launched Immortals, a program offering his exact protocol to three clients at $1 million per year each.

What is Bryan Johnson’s net worth in 2026?

Bryan Johnson’s net worth is estimated at $400 million to $500 million in 2026. His primary wealth came from selling Braintree (which included Venmo) to PayPal for $800 million in 2013. Subsequent investments through OS Fund, his stake in Kernel neurotechnology, and Blueprint-related revenue contribute to the total. The figure has likely decreased from the post-sale peak due to significant reinvestment in his companies and longevity research.

What supplements does Bryan Johnson take daily?

Bryan Johnson’s 2026 supplement stack includes more than 100 compounds. Core supplements include NMN or NR (to boost NAD+ levels for DNA repair), calcium alpha-ketoglutarate (lifespan extension and inflammation reduction), and spermidine (supports autophagy). Additional compounds include fisetin (a senolytic targeting aging cells), resveratrol (mitochondrial support), NDGA at 50mg daily (antioxidant), and CoQ10 (cellular energy). The stack is continuously adjusted based on biomarker data from his medical team.

Can you follow Bryan Johnson’s protocol without spending millions?

Yes. Johnson publishes his full protocol for free on his Blueprint website. The core principles (quality sleep, calorie-controlled nutrition, consistent exercise, targeted supplementation, and biomarker tracking) can be followed at a range of price points. East End longevity clinics like Hamptons BioMed in Southampton offer NAD+ drips, red light therapy, hyperbaric oxygen, and epigenetic counseling at costs ranging from $500 to $20,000 per season, delivering a significant portion of what Johnson’s $2 million protocol provides.